TG Therapeutics Inc
Biotechnology
Healthcare
TGTX
161 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
34.59
52 week high
42.99
high
37.17
52 week low
15.85
low
31.01
growth
119.94 %
previous Close
35.53
P/E ratio
market cap
5.06 B
div yield
0
net incoming
3.88 M
-43.60 %
net profit margin
4.63 %
-4.00 %
operating incoming
12.43 M
41.04 %
net change in cash
114 M
1.00 %
cash on hand
196 M
136.19 %
cost of revenue
9.34 M
11.52 %
top